[1]
|
Yutaka, T. (2017) The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver. International Journal of Molecular Sciences, 18, Article No. 1447. https://doi.org/10.3390/ijms18071447
|
[2]
|
Yakar, S., Rosen, C.J., Beamer, W.G., Ackert-Bicknell, C.L., Wu, Y., Liu, J.L., et al. (2002) Circulating Levels of IGF-1 Di-rectly Regulate Bone Growth and Density. Journal of Clinical Investigation, 110, 771-781.
https://doi.org/10.1172/JCI0215463
|
[3]
|
Ekberg, S., Luther, M., Nakamura, T. and Jansson, J.-O. (1992) Growth Hormone Promotes Early Initiation of Hepatocyte Growth Factor Gene Expression in the Liver of Hy-pophysectomized Rats after Partial Hepatectomy. Journal of Endocrinology, 135, 59-67. https://doi.org/10.1677/joe.0.1350059
|
[4]
|
Krupczak-Hollis, K., Wang, X., Dennewitz, M.B. and Costa, R.H. (2003) Growth Hormone Stimulates Proliferation of Old-Aged Regenerating Liver through Forkhead Box m1b. Hepatology, 38, 1552-1562.
https://doi.org/10.1016/j.hep.2003.08.052
|
[5]
|
Pennisi, P.A., Kopchick, J.J., Snorri, T., LeRoith, D. and Yakar, S. (2004) Role of Growth Hormone (GH) in Liver Regeneration. Endocrinology, 145, 4748-4755. https://doi.org/10.1210/en.2004-0655
|
[6]
|
Laron, Z., Ginsberg, S. and Webb, M. (2008) Nonalcoholic Fatty Liver in Patients with Laron Syndrome and GH Gene Deletion—Preliminary Report. Growth Hormone & IGF Research, 18, 434-438.
https://doi.org/10.1016/j.ghir.2008.03.003
|
[7]
|
Singeap, A.M., Stanciu, C., Huiban, L., Muzica, C.M., Cuci-ureanu, T., Girleanu, I., et al. (2021) Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications. Canadian Journal of Gastroenterology and Hepatology, 2021, Article ID: 6678142. https://doi.org/10.1155/2021/6678142
|
[8]
|
Ichikawa, T., Nakao, K., Hamasaki, K., Furukawa, R., Tsuruta, S., Ueda, Y., Taura, N., Shibata, H., Fujimoto, M., Toriyama, K., et al. (2007) Role of Growth Hormone, Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Development of Non-Alcoholic Fatty Liver Disease. Hepatology International, 1, 287-294.
https://doi.org/10.1007/s12072-007-9007-4
|
[9]
|
Cai, C., Song, X., Chen, Y., Chen, X. and Yu, C. (2019) Relationship between Relative Skeletal Muscle Mass and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Hepatology International, 14, 115-126.
https://doi.org/10.1007/s12072-019-09964-1
|
[10]
|
Zvibel, I., Atias, D., Phillips, A., Halpern, Z. and Oren, R. (2010) Thyroid Hormones Induce Activation of Rat Hepatic Stellate Cells through Increased Expression of p75 Neurotrophin Receptor and Direct Activation of Rho. Laboratory Investigation, 90, 674-684. https://doi.org/10.1038/labinvest.2010.48
|
[11]
|
Kander, M.C., Cui, Y. and Liu, Z. (2016) Gender Difference in Oxidative Stress: A New Look at the Mechanisms for Cardiovascular Diseases. Journal of Cellular and Molec-ular Medicine, 21, 1024-1032.
https://doi.org/10.1111/jcmm.13038
|
[12]
|
Harada, N., Hanaoka, R., Hanada, K., Izawa, T., Inui, H. and Yamaji, R. (2016) Hypogonadism Alters Cecal and Fecal Microbiota in Male Mice. Gut Microbes, 7, 533-539. https://doi.org/10.1080/19490976.2016.1239680
|
[13]
|
Hazlehurst, J.M., Gathercole, L.L., Nasiri, M., Arm-strong, M.J., Borrows, S., Yu, J., et al. (2013) Glucocorticoids Fail to Cause Insulin Resistance in Human Subcu-taneous Adipose Tissue in Vivo. The Journal of Clinical Endocrinology & Metabolism, 98, 1631-1640. https://doi.org/10.1210/jc.2012-3523
|
[14]
|
Li, G., Hernandez-Ono, A., Crooke, R.M., Graham, M.J. and Ginsberg, H.N. (2011) Effects of Antisense-Mediated Inhibition of 11-Hydroxysteroid Dehydrogenase Type 1 on Hepatic Lipid Metabolism. Journal of Lipid Research, 52, 971-981. https://doi.org/10.1194/jlr.M013748
|
[15]
|
Prasad Sakamuri, S.S.V., Sukapaka, M., Prathipati, V.K., Nemani, H., Putcha, U.K., Pothana, S., et al. (2012) Carbenoxolone Treatment Ameliorated Metabolic Syndrome in WNIN/Ob Obese Rats, but Induced Severe Fat Loss and Glucose Intolerance in Lean Rats. PLOS ONE, 7, Article ID: e50216. https://doi.org/10.1371/journal.pone.0050216
|
[16]
|
Lavery, G.G., Zielinska, A.E., Gathercole, L.L., Hughes, B., Semjonous, N., Guest, P., et al. (2012) Lack of Significant Metabolic Abnormalities in Mice with Liver-Specific Disruption of 11β-Hydroxysteroid Dehydrogenase Type 1. Endocrinology, 153, 3236-3248. https://doi.org/10.1210/en.2012-1019
|
[17]
|
肝脏穿刺活检湘雅专家共识编写组. 肝脏穿刺活检湘雅专家共识[J]. 中国普通外科杂志, 2021, 30(1): 1-8.
|
[18]
|
Bell, J., Parker, K.L., Swinford, R.D., Hoffman, A.R., Maneatis, T. and Lippe, B. (2010) Long-Term Safety of Recombinant Human Growth Hormone in Children. The Journal of Clinical Endocrinology & Metabolism, 95, 167-177.
https://doi.org/10.1210/jc.2009-0178
|
[19]
|
袁仙仙, 陈适, 阳洪波, 王林杰, 潘慧, 朱惠娟. 全垂体功能减退合并肝硬化3例及文献综述[J]. 济宁医学院学报, 2018, 41(2): 92-96+101.
|